English Polski
Vol 14, No 4 (2019)
Conference report / Report
Published online: 2018-09-14

open access

Page views 554
Article views/downloads 416
Get Citation

Connect on Social Media

Connect on Social Media

Novel synthesis of magnetic nanoparticles conjugation with perfluorocarbon nanobubbles for potential adjunct therapy of acute myocardial ischaemia

Mark C. Arokiaraj1
DOI: 10.5603/FC.a2018.0095
Folia Cardiologica 2019;14(4):425-427.

Abstract

Introduction. This study was performed in search of a novel adjunct agent for myocardial salvage in acute myocardial ischaemia. Methods and results. This is a report of conjugation between perfluorocarbon nanobubbles with multifunctional biocompatible magnetic nanoparticles. It was possible to synthesise the conjugation of multifunctional biocompatible magnetic nanoparticles with perfluorocarbon nanobubbles. The potential nano-size magnetic product could cross the deranged endothelial borders in the ischaemic penumbra regions, and could help in myocardial salvage. Furthermore, the particles could be focused to the target region using the magnetic micromesh technique. Conclusions. A conjugation between magnetic nanoparticles and PFC nano-bubbles is possible. Further studies need to be performed to explore the potential uses.

Article available in PDF format

View PDF Download PDF file

References

  1. Gao Z, Kennedy AM, Christensen DA, et al. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst. 2007; 99(14): 1095–1106.
  2. Pankhurst QA, Thanh N, Jones SK, et al. Progress in applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys. 2009; 42(22): 224001.
  3. Dobson J. Remote control of cellular behaviour with magnetic nanoparticles. Nat Nanotechnol. 2008; 3(3): 139–143.
  4. Fu A, Wilson RJ, Smith BR, et al. Fluorescent magnetic nanoparticles for magnetically enhanced cancer imaging and targeting in living subjects. ACS Nano. 2012; 6(8): 6862–6869.
  5. Iyer AK, Khaled G, Fang J, et al. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006; 11(17-18): 812–818.
  6. Rapoport N, Marin A, Christensen D. Ultrasound-activated micellar drug delivery. Drug Delivery Syst Sci. 2002; 2: 37–46.
  7. Moncion A, Arlotta KJ, Kripfgans OD, et al. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol. 2000; 26(7): 1177–1189.
  8. Husseini GA, Diaz de la Rosa MA, Richardson ES, et al. The role of cavitation in acoustically activated drug delivery. J Control Release. 2005; 107(2): 253–261.
  9. Arokiaraj MC, Menesson E, Cereijo U, et al. A novel method for prevention of hypoxic cardiomyocyte injury. Cardiology in Belarus. 2019; 11: 3.